Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Marc Vasse, Anne Verrat et al.|Journal of Clinical Immunology|2020Cited by 53
An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 VaccinesAlexandre Vallée, Erwan Fourn, Marc Vasse et al.|Journal of Clinical Medicine|2021Cited by 20
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study—IMEA 055Antoine Bachelard, Fatima Touam, Valentina Isernia et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 14
Increase in sexually transmitted infections in a cohort of outpatient HIV-positive men who have sex with men in the Parisian regionÉric Farfour, David Zucman, Svetlane Dimi et al.|Médecine et Maladies Infectieuses|2017Cited by 7